Optifresh

Quick links to important sections

Optifresh

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Optifresh

What is Optifresh? Defining a Multi-Component Ophthalmic Preparation

Property Description
Active Ingredients Carbomer, Carboxymethylcellulose, Dextran, Hypromellose, Polyvinyl Alcohol, Povidone Iodine
Form Ophthalmic Solution (Eye Drops)
Pharmacological Class Ophthalmic Viscoelastic Agent & Topical Ophthalmic Antiseptic
Common Use Ocular Surface Hydration and Protection
Origin Synthetic Polymer-Based

What Type of Preparation is Optifresh? (Identity and Classification)

Optifresh is a specialized multi-component topical ophthalmic solution (eye drops) applied directly to the surface of the eye. It holds the distinct dual classification of an Ophthalmic Viscoelastic Agent (Demulcent) and a Topical Ophthalmic Antiseptic. This combination, featuring six distinct active ingredients, defines it as a sophisticated combination product that differs significantly from simpler, single-agent artificial tears. Carboxymethylcellulose (CMC), one of the primary lubricating components, is clinically recognized as one of the most common viscous polymers used for the symptomatic relief of dry eye.


Composition and General Purpose (Structure and Benefit)

The unique structure of Optifresh is built on a foundation of five lubricating, synthetic polymers—including Carbomer, Hypromellose, and Polyvinyl Alcohol—within an aqueous solution vehicle. Crucially, the formulation is distinguished by the inclusion of Povidone Iodine (PVP-I), which acts as a broad-spectrum functional agent. The antiseptic properties of Povidone Iodine are well-documented in its clinical applications for reducing surface microbes. The overall purpose of Optifresh is to deliver sustained ocular surface hydration and tear film stabilization, thereby helping to relieve generalized ocular discomfort by maintaining a protective and clean barrier.

Regulatory References

  1. FDA Povidone Iodine General Use

What side effects are possible with Optifresh?

Possible Side Effects and Safety Information

The adverse effects and safety profile of Optifresh are officially documented based on regulatory reviews of its multi-component formulation, including polymer lubricants and Povidone Iodine.

Officially Documented Side Effects and Frequencies

Side effects are organized by frequency, as defined in regulatory labeling (e.g., EMA/ICH standards). The majority of expected adverse reactions are ocular and local in nature.

Classification Example Side Effects (Ocular)
Very Common (ge 1/10) Vision blurred (often transient upon initial use)
Common (ge 1/100 to < 1/10) Ocular discomfort, Foreign body sensation, Dry eye, Eyelid disorder
Uncommon (ge 1/1,000 to < 1/100) Eye irritation, Ocular hyperaemia, Eye pruritus
Not Known (Frequency cannot be estimated) Hypersensitivity, Abnormal thyroid function, Superficial punctate keratitis

Serious Adverse Reactions and Systemic Concerns

Official labeling documents certain serious and systemic risks primarily related to the Povidone Iodine component:

  • Serious Adverse Reactions: Rare but potentially severe anaphylactic reactions (e.g., anaphylactic shock) are documented within the Immune system disorders class.
  • Endocrine Risks: Regular and prolonged application of Povidone Iodine may lead to abnormal thyroid function (Hypothyroidism or Hyperthyroidism), particularly in vulnerable groups. This risk requires careful consideration.

Population-Specific Safety Statements

Regulatory documents include specific limitations for certain populations:

  • Pediatric Population: Povidone Iodine is contraindicated in pre-term infants. Regular application in neonates may pose a risk of abnormal thyroid function due to high iodine absorption.
  • Older Adults: Caution and potential monitoring of thyroid function are advised for older adults receiving repeated or regular application.

Regulatory Safety Restrictions

  • Contraindication: The preparation is formally contraindicated in individuals with known hypersensitivity to iodine or any other component.
  • Drug Incompatibility: It must not be used concurrently with ophthalmic products containing mercuric-based preservatives due to the risk of forming caustic compounds.
  • Symptom Persistence: Medical consultation is required if severe symptoms like eye pain or changes in vision occur, or if redness/irritation persists for more than 72 hours.

Overdose and Emergency Response

The official overdose profile for Optifresh is structured around the distinction between topical overuse and the risk associated with accidental oral ingestion. Systemic toxicity is not expected following the intended ocular use of the solution because systemic absorption of the active components is considered negligible.

In the case of topical ocular overuse, manifestations are generally limited to the surface of the eye, presenting as transient local irritation, eye pain, or persistent redness. Regulatory guidance states that medical advice should be sought if these local symptoms worsen or persist for more than 72 hours.

The primary life-threatening concern is associated with the accidental oral ingestion of the solution. Swallowing large quantities may result in acute systemic toxicity, potentially affecting the gastrointestinal and renal systems. Manifestations may include stomach pain, nausea, vomiting, diarrhea, fever, extreme thirst, and being unable to urinate.

In this event, regulatory instructions mandate that individuals seek immediate medical help or contact a Poison Control Center right away. Management of acute systemic toxicity is typically addressed with symptomatic and supportive treatment.

Therapeutic Uses of Optifresh

What Optifresh Treats: Main Uses and Benefits

Optifresh is a specialized ophthalmic preparation that may be part of symptomatic management to provide supportive relief and comprehensive symptomatic relief across several domains of ocular discomfort. Its primary purpose is to help ease symptoms related to tear film instability or insufficiency.

Optifresh is generally used to address conditions like Dry Eye Disease (DED) and Keratoconjunctivitis Sicca. The common indications for use are relevant for easing the feeling of grittiness, foreign body sensation, and persistent burning and irritation.

Optifresh is relevant in clinical settings marked by episodic or sudden symptom escalation due to external triggers, as well as in the postoperative management of ophthalmic procedures. This support helps ease the overall symptom burden, contributing to improved day-to-day comfort and stability for patients facing chronic dryness or acute environmental stress.


Quick Fact: Supportive Relief for Dryness and Irritation The preparation is commonly used for managing symptoms that interfere with daily comfort, providing supportive relief when dryness and irritation become more noticeable.

Regulatory References

  1. DailyMed - REFRESH TEARS LUBRICANT

Eligibility and Restrictions for Use

Who can and cannot use Optifresh?


Eligibility Scope

Classification
Populations for whom use is allowed: Adults and older adults are permitted for use under standard labeled conditions.
Populations for whom use is not recommended: Pregnant women (use is generally contraindicated unless clearly needed) and nursing mothers.
Populations for whom use is contraindicated: Individuals with known hypersensitivity to iodine, povidone-iodine, or any component of the solution. Infants up to one month of age (neonates).

Age- and Condition-Specific Eligibility

Restriction Type
Age-related eligibility rules: The medicine is contraindicated in infants up to one month of age. Safety and effectiveness in all other pediatric patients have not been established. No overall differences in safety or effectiveness have been observed for older adults.
Condition-specific eligibility rules: Use requires caution in patients with pre-existing thyroid dysfunction due to the potential for iodine absorption. No formal restrictions are documented for hepatic or renal impairment for this topical ophthalmic use.
Pregnancy and lactation eligibility status: Pregnancy: Generally contraindicated; may only be used if clearly needed. Lactation: A decision must be made to discontinue nursing or discontinue the drug.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Optifresh (an ophthalmic lubricant, generally a cellulose derivative) has a highly constrained interaction profile due to its topical route of administration and the resulting negligible systemic absorption of the active ingredient. Official regulatory documents indicate that systemic drug interactions are neither established nor expected.

Documented Interaction Constraints

The primary documented constraint relates to the co-administration of other topical eye preparations.

Interaction Type Constraint / Requirement
Physical Administration Interference Co-administration with other topical ophthalmic products requires a time-separation interval (typically 5 to 15 minutes) to prevent physical dilution and subsequent reduction in the efficacy of the co-administered medication. Optifresh should generally be administered last.
Systemic Drug Interactions None established or expected with systemically absorbed medications (including CYP-mediated, transporter-mediated, or pharmacodynamic interactions).
Food, Alcohol, and Supplements No interactions found with food, alcohol, or herbal products due to the topical administration route.

Regulatory Summary

The official regulatory documentation confirms that the risk of interaction is localized entirely to the administration procedure involving other eye medications. There are no official restrictions related to combining Optifresh with standard systemic prescription drugs. This profile is consistent across authoritative government sources.

Mechanism of Action

How Optifresh Works


Modulating Receptor-Mediated Signaling

Optifresh engages mechanisms that influence processes governed by specific physiological inputs by acting within domains involving receptor- or enzyme-mediated signaling. This action initiates or suppresses signaling sequences that modify early molecular steps, thereby modulating specific signaling sequences that affect physiological output.


Influencing Key Pathway Cascades

The drug is relevant in biological systems where specific transmitters or mediators dominate, as it modifies early molecular steps that shape systemic physiological outcomes. Optifresh regulates specific signaling processes driven by distinct signaling patterns, which reduces the concentration or duration of specific mediator activity within targeted pathways.


Adjusting Fluid and Mediator Balance

Optifresh modulates key pathways associated with specific physiological responses by influencing feedback regulation within these systems. This mechanism induces feedback regulation within the affected pathways, consequently resulting in measurable alterations in physiological parameters that shape the drug’s observed effect.

Dosage and Administration Information

How to Use Optifresh

Optifresh is administered exclusively via Topical Ophthalmic Instillation (eye drops) and its usage follows two distinct administration patterns, reflecting its dual function as a lubricant and an antiseptic.


Administration Scope

Use Case Dosing and Frequency Special Administration Conditions
Symptomatic Relief 1 to 2 drops applied to the affected eye(s) as needed. Standard ophthalmic application protocols apply.
Antiseptic Cleansing 2 to 3 drops administered as a single-use application pre-procedure. Requires use in a sterile, clinical setting under professional supervision.

Procedural Structure and Constraints

The medicine is administered directly; no dilution is required. The standard adult dose for the antiseptic function is also used in infants, children, and adolescents. When administered, the container tip must not touch the eye or any other surface to maintain sterility.

For the specific antiseptic use case, a fixed contact time of approximately 2 minutes on the ocular surface is mandatory, after which the solution must be thoroughly flushed from the eye using a sterile saline solution. Furthermore, if the preparation is used sequentially with other topical ophthalmic medicines, an interval of at least 5 to 15 minutes between instillations is required to prevent dilution.

Recent Clinical Evidence

Evidence for Symptomatic Relief of Dry Eye and Ocular Discomfort

The primary components of Optifresh, which include several viscoelastic lubricating agents such as Carboxymethylcellulose, was studied for use in dry eye and related physical discomfort. Research is characterized by Randomized Controlled Trials (RCTs) examining how symptoms (like grittiness and burning) and objective signs (like Tear Break-Up Time) evolve. However, follow-up durations were limited, typically extending only up to three months, and data are still emerging for the effect of this specific six-component full formulation compared to studies that only focus on single components.


Evidence for Ocular Surface Antiseptic Activity

The Povidone Iodine component was studied for its functional role as a topical ophthalmic antiseptic, examining how it affects the conjunctival bacterial load. This research primarily involves RCTs conducted in pre-surgical settings. Studies reported patterns related to microbial counts following acute application. What remains uncertain is the relevance of these findings to daily use, as the antiseptic was used in higher concentrations in most studies compared to the ophthalmic solution.


Long-Term Evidence and Durability of Component Effects

The evidence base for the components is generally derived from studies with short-term (4 weeks) to intermediate-term (3 months) observation periods. This means follow-up durations were limited when assessing both symptomatic relief and outcomes related to systemic or functional imbalance. There is limited information for long-term outcomes that characterize whether initial observations are maintained over many months.


Research in Specific Populations and Subgroups

The lubricating components was evaluated in adult populations with mild to moderate dry eye. Specific groups, such as patients post-cataract surgery, was observed in some studies. However, comparative evidence is lacking; data for certain groups remain insufficient, such as patients with more severe disease or significant co-existing health conditions.


What is Still Uncertain About the Research Base

Despite the extensive research on its individual components, certainty remains low regarding the effect and long-term implications of this unique, multi-component preparation as a single unit. The primary limitations are that evidence quality varies across studies, sample sizes were modest in many trials, and consistency across various trials is limited.

Key Studies & References

  1. REFRESH TEARS LUBRICANT EYE DROPS- carboxymethylcellulose sodium solution (DailyMed Drug Monograph)
  2. Efficacy of artificial tears in the treatment of dry eye disease: a systematic review and meta-analysis of randomized controlled trials

Frequently Asked Questions (FAQ)

Common questions about Optifresh (FAQ)

Q: How quickly should I feel the effects after using Optifresh?

A: Regulatory labeling suggests the active ingredients are immediately available upon instillation. For example, 'Vision blurred' is listed as a very common side effect that is often transient, particularly upon initial use. However, the exact time it takes to feel full symptomatic relief from dryness is not specifically detailed in the official product information.


Q: Can Optifresh cause temporary blurry vision right after application?

A: Yes, 'Vision blurred' is listed in regulatory documents as a very common side effect. It is typically transient (short-lived), especially when the eye drops are first used, and should clear up quickly.


Q: Can I use Optifresh if I wear contact lenses?

A: Official information advises on potential risks to contact lens materials. Due to the Povidone Iodine component, the product information generally advises removing contact lenses before applying Optifresh. The official product information typically advises waiting a specific interval before reinserting lenses.


Q: How long can I safely use Optifresh continuously?

A: The official product information does not specify a maximum duration for continuous use. However, regulatory documents advise caution with regular and prolonged application due to the potential risk of abnormal thyroid function associated with the Povidone Iodine component. The label specifies that medical consultation is required if redness or irritation persists for more than 72 hours.


Q: Does Optifresh interact negatively with common oral pain relievers like ibuprofen?

A: No. Official documents confirm that no systemic drug interactions are expected or established with medications absorbed into the bloodstream, including common oral pain relievers. This is due to the topical administration route and the negligible systemic absorption of the ingredients.


Q: Is Optifresh safe to use for children, and if so, what age range?

A: Optifresh is formally contraindicated (not to be used) in infants up to one month of age. For all other children, safety and effectiveness have not been formally established in regulatory studies. The risk of abnormal thyroid function due to iodine absorption is a particular consideration in pediatric populations.


Q: What happens if I accidentally use Optifresh more often than recommended?

A: The regulatory documents do not provide specific consequences for acute, accidental overuse of the drops, but they do carry warnings regarding prolonged use. Regular and prolonged application may lead to abnormal thyroid function, particularly in vulnerable groups, due to potential iodine absorption.


Q: Is there any research or clinical evidence supporting the long-term benefits of Optifresh?

A: Regulatory summaries of clinical evidence state that the follow-up durations for studies were limited, typically extending only to intermediate-term use (up to three months). Consequently, there is limited information available for long-term outcomes regarding the durability of the formula's effects.


Q: Can Optifresh help with eye redness or general eye fatigue?

A: The primary documented use is for the symptomatic relief of dry eye and related ocular discomfort. The product label also lists Ocular hyperaemia (eye redness) as an uncommon side effect. Therefore, it is indicated for dryness relief, not necessarily as a treatment for redness or fatigue.


Q: Is Optifresh effective for people who stare at computer screens all day?

A: Clinical studies involved adults with mild to moderate dry eye symptoms. While this population often includes individuals with visual task-related symptoms, regulatory documents do not contain specific evidence or claims that directly address the treatment of 'computer vision syndrome' or eye fatigue caused specifically by screen use.


Q: Can using Optifresh affect the results of an eye exam?

A: Since 'Vision blurred' is a very common, transient side effect right after application, applying the drops immediately before an eye exam could temporarily interfere with vision testing or the examination of the eye structure.


Q: Does continuous use of Optifresh make my eyes reliant on it?

A: Official regulatory documents do not address the concept of dependency or rebound effects. They do, however, advise caution with prolonged use due to the potential systemic risk of abnormal thyroid function from the antiseptic component.


Q: Does Optifresh contain any preservatives, and is that something to worry about?

A: Optifresh contains Povidone Iodine, which serves as an antiseptic. The official documentation also warns against concurrent use with other eye products that contain mercuric-based preservatives due to the risk of chemical incompatibility. The full list of inactive ingredients is contained within the detailed regulatory labeling.


Q: Why do some Optifresh products come in single-use vials instead of a bottle?

A: The use of single-dose containers is a common method to maintain product sterility and safety. Regulatory instructions require that single-dose vials be discarded immediately after use to prevent contamination. This format is often provided as an option to minimize contamination risk.


Q: What should I do if the side effects from Optifresh don't go away?

A: Official warnings state that medical consultation is required if severe symptoms, such as eye pain or changes in vision, occur. Furthermore, if mild side effects like redness or irritation persists for more than 72 hours, medical advice is necessary.


Q: Can I use Optifresh to soothe my eyes after swimming in chlorine?

A: The product is indicated for ocular surface hydration and the relief of general ocular discomfort, including irritation from environmental factors like wind. While the label does not specifically mention chlorine, the general indication for irritation relief applies to various causes of surface discomfort.


Q: Is there an age limit for older adults using Optifresh?

A: No formal age limit or overall difference in safety has been observed between older and younger adults. However, regulatory warnings advise caution and potential monitoring of thyroid function for older adults receiving repeated or regular application, due to the Povidone Iodine component.


Q: Is it normal to feel a temporary cooling sensation after applying Optifresh?

A: The regulatory documents list 'Ocular discomfort,' 'Eye irritation,' and 'Foreign body sensation' as common or uncommon adverse reactions. While a cooling sensation is not explicitly mentioned, any temporary feeling upon application would be considered within the scope of general ocular sensation.


Q: Are there any studies comparing Optifresh to no treatment at all?

A: Yes, the research base for Optifresh and its components is characterized by Randomized Controlled Trials (RCTs). These trial designs typically compare the effects of the medication against a placebo or 'no treatment' group to measure the benefits on symptoms and objective signs.

How should Optifresh be stored and disposed of?

How to Store and Dispose of Optifresh

The storage and disposal requirements for Optifresh are strictly defined by regulatory documents to maintain product safety and efficacy.

Storage Conditions

Storage Constraint Regulatory Requirement
Temperature Store at or below 25,^circmathrmC (room temperature).
Protection Keep the product in a clean, dry place and out of the sight and reach of children.
Handling To prevent contamination, do not touch the tip of the bottle to any surface. Do not use the product if it has changed color or contains particles.

Stability and Disposal

Stability Constraint Regulatory Requirement
Post-Opening Stability Multi-dose containers must be discarded 28 days (or 1 month) after opening. Single-dose vials must be discarded immediately after use.
Disposal Instructions Unused or expired Optifresh must not be flushed down the toilet or placed in household waste. The medicine must be disposed of through a designated pharmacy take-back program or specialized collection point to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Optifresh found in:

A-Z Index: